|
Editorial
|
|
MUM1: a step ahead toward the understanding of lymphoma histogenesis
|
563
|
|
G Gaidano & A Carbone
|
| Abstract Full Article PDF
|
 |
|
|
Review
|
|
Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia
|
567
|
|
HL McLeod, EY Krynetski, MV Relling & WE Evans
|
| Abstract Full Article PDF
|
| |
|
|
Original Manuscripts
|
|
Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes
|
573
|
|
F Lefrère, O Hermine, C Belanger, S François, H Tilly, J-C Lebas de La Cour, F Valensi, B Varet & X Troussard
|
| Abstract Full Article PDF
|
| |
|
Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias
|
576
|
|
AE Frankel, JA McCubrey, MS Miller, S Delatte, J Ramage, M Kiser, GL Kucera, RL Alexander, M Beran, EP Tagge, RJ Kreitman & DE Hogge
|
| Abstract Full Article PDF
|
| |
|
Methylation status of the p15INK4B gene in hematopoietic progenitors and peripheral blood cells in myelodysplastic syndromes
|
586
|
|
E Aoki, T Uchida, H Ohashi, H Nagai, T Murase, A Ichikawa, K Yamao, T Hotta, T Kinoshita, H Saito & T Murate
|
| Abstract Full Article PDF
|
| |
|
The interaction between EEN and Abi-1, two MLLfusion partners, and synaptojanin and dynamin: implications for leukaemogenesis
|
594
|
|
CW So, CKC So, N Cheung, SL Chew, MH Sham & LC Chan
|
| Abstract Full Article PDF
|
| |
|
Sensitisation of HL60 human leukaemic cells to cytotoxic drug-induced apoptosis by inhibition of PI3-kinase survival signals
|
602
|
|
DM O'Gorman, SL McKenna, AJ McGahon, KA Knox & TG Cotter
|
| Abstract Full Article PDF
|
| |
|
Induction of apoptosis in human hematopoietic U937 cells by granulocyte–macrophage colony-stimulating factor: possible existence of caspase 3-like pathway
|
612
|
|
E Okuma, K Saeki, M Shimura, Y Ishizaka, E Yasugi & A Yuo
|
| Abstract Full Article PDF
|
| |
|
Mechanisms of resistance to apoptosis in human AML blasts: the role of differentiation-induced perturbations of cell-cycle checkpoints
|
620
|
|
NJ Ketley, PD Allen, SM Kelsey & AC Newland
|
| Abstract Full Article PDF
|
| |
|
Characterization of a novel negative regulatory element in the human interleukin 4 promoter
|
629
|
|
S Georas, J Cumberland, T Burke, E Park, S Ono & V Casolaro
|
| Abstract Full Article PDF
|
| |
|
Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients
|
636
|
|
G Rossi, AM Pelizzari, D Bellotti, M Tonelli & S Barlati
|
| Abstract Full Article PDF
|
| |
|
Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism
|
642
|
|
PE Hoyle, PW Moye, LS Steelman, WL Blalock, RA Franklin, M Pearce, H Cherwinski, E Bosch, M McMahon & JA McCubrey
|
| Abstract Full Article PDF
|
| |
|
Identification of a genetic locus modulating splenomegaly induced by granulocyte colony-stimulating factor in mice
|
657
|
|
AW Roberts, M Hasegawa, D Metcalf & SJ Foote
|
| Abstract Full Article PDF
|
| |
|
Biological effects induced by variable levels of BCR-ABL protein in the pluripotent hematopoietic cell line UT-7
|
662
|
|
C Issaad, M Ahmed, S Novault, ML Bonnet, T Bennardo, B Varet, W Vainchenker & AG Turhan
|
| Abstract Full Article PDF
|
| |
Immunoglobulin  gene rearrangements between the deleting element and J recombination signal sequences in acute lymphoblastic leukemia and normal hematopoiesis
|
671
|
|
T Seriu, TE Hansen-Hagge, Y Stark & CR Bartram
|
| Abstract Full Article PDF
|
| |
|
Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene
|
675
|
|
WJC Rombouts, I Blokland, B Löwenberg & RE Ploemacher
|
| Abstract Full Article PDF
|
| |
|
Prognostic factors in infants with acute myeloid leukemia
|
684
|
|
C-H Pui, SC Raimondi, DK Srivastava, X Tong, FG Behm, B Razzouk, JE Rubnitz, JT Sandlund, WE Evans & R Ribeiro
|
| Abstract Full Article PDF
|
| |
|
Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy
|
688
|
|
EG van Lochem, YM Wiegers, R van den Beemd, K Hählen, JJM van Dongen & H Hooijkaas
|
| Abstract Full Article PDF
|
| |
|
Expression of a functional inducible nitric oxide synthase in hairy cell leukaemia and ESKOL cell line
|
696
|
|
V Roman, H Zhao, J-M Fourneau, A Marconi, N Dugas, B Dugas, F Sigaux & J-P Kolb
|
| Abstract Full Article PDF
|
| |
|
P53 mutations in hairy cell leukemia
|
706
|
|
EA König, WC Kusser, C Day, F Porzsolt, BW Glickman, G Messer, M Schmid, R de Châtel, ZL Marcsek & J Demeter
|
| Abstract Full Article PDF
|
| |
|
Ex vivo assessment of drug response by differential staining cytotoxicity (DiSC) assay suggests a biological basis for equality of chemotherapy irrespective of age for patients with chronic lymphocytic leukaemia
|
712
|
|
AG Bosanquet & MI Bosanquet
|
| Abstract Full Article PDF
|
| |
|
Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma
|
716
|
|
A Bazarbachi, R Nasr, ME El-Sabban, A Mahé, R Mahieux, A Gessain, N Darwiche, G Dbaibo, J Kersual, Y Zermati, L Dianoux, MK Chelbi-Alix, H de Thé & O Hermine
|
| Abstract Full Article PDF
|
| |
|
The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation
|
722
|
|
M Vickers, G Jackson & P Taylor
|
| Abstract Full Article PDF
|
| |
|
Stromal cell-independent differentiation of human cord blood CD34+CD38- lymphohematopoietic progenitors toward B cell lineage
|
727
|
|
Y Yoshikawa, F Hirayama, M Kanai, S Nakajo, J Ohkawara, M Fujihara, M Yamaguchi, N Sato, M Kasai, S Sekiguchi & K Ikebuchi
|
| Abstract Full Article PDF
|
| |
|
The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability
|
735
|
|
MG Cipolleschi, E Rovida, Z Ivanovic, V Praloran, M Olivotto & P Dello Sbarba
|
| Abstract Full Article PDF
|
| |
|
Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft
|
740
|
|
C Tarella, D Caracciolo, P Corradini, F Zallio, M Ladetto, A Cuttica, G Rossi, D Novero, P Gavarotti & A Pileri
|
| Abstract Full Article PDF
|
| |
|
Variation in the frequency of Epstein–Barr virus-associated Hodgkin's disease with age
|
748
|
|
KJ Flavell, JP Biddulph, CM Constandinou, D Lowe, K Scott, J Crocker, LS Young & PG Murray
|
| Abstract Full Article PDF
|
| |
|
A real-time PCR assay for the quantification of residual malignant cells in B cell chronic lymphatic leukemia
|
754
|
|
T Pfitzner, A Engert, H Wittor, T Schinköthe, F Oberhäuser, H Schulz, V Diehl & S Barth
|
| Abstract Full Article PDF
|
| |
|
|
Correspondence
|
|
Digoxigenin-end labeled oligonucleotides facilitate the detection of minimal residual disease in acute lymphoblastic leukemia
|
767
|
|
M Nakao, JWG Janssen, M Schäfer & CR Bartram
|
| Full Article PDF
|
| |
|
Leukaemic expression of anaplastic large cell lymphoma with 46,XX,ins(2;5)(p23;q15q35) in a child with dihydropyrimidine dehydrogenase deficiency
|
769
|
|
H van den Berg, A Noorduyn, ABP van Kuilenburg, W Kroes & D de Jong
|
| Full Article PDF
|
| |
|
Discordant expression of AC133 and AC141 in patients with myelodysplastic syndrome (MDS) and acute myelogeneous leukemia (AML)
|
770
|
|
CL Green, M Loken, D Buck & HJ Deeg
|
| Full Article PDF
|
| |
| |
| |
